dpp 4 inhibitors and glp 1 GLP-1-RA DPP-4 in the management of type 2 diabetes Insight into Structure Activity Relationship

They are looking for red flags: commercial quantities, controlled substances, unpackaged medications, and people who seem evasive about what they are carrying

Acne (especially jawline, chin, lower-face) Spironolactone went from off-label option to evidence-based first-line for adult female acne in 2023 with the SAFA trial a UK multicenter, double-blind, placebo-controlled RCT of 410 women published in The BMJ and Health Technology Assessment

The nano-semaglutide and microneedle claims made by Patched GLP-1 are marketing claims with no clinical proof

The trial currently has almost 10,000 patients enrolled and is expected to assess a composite MACE endpoint consisting of cardiovascular (CV) death, non-fatal myocardial infarction, or non-fatal stroke in patients with T2D as is expected to readout in July 2024 (NCT03574597)

labels for these medications